Vitalhub (TSE:VHI) Price Target Raised to C$8.00

Vitalhub (TSE:VHIFree Report) had its target price lifted by Cormark from C$7.50 to C$8.00 in a research note issued to investors on Tuesday morning, BayStreet.CA reports.

Separately, Canaccord Genuity Group lifted their price target on shares of Vitalhub from C$7.50 to C$8.00 and gave the stock a buy rating in a report on Monday, May 13th.

Check Out Our Latest Analysis on Vitalhub

Vitalhub Price Performance

Vitalhub stock opened at C$7.44 on Tuesday. The firm has a market cap of C$377.13 million, a PE ratio of 74.40, a price-to-earnings-growth ratio of 2.61 and a beta of 1.23. The stock’s fifty day moving average price is C$6.64 and its two-hundred day moving average price is C$5.58. Vitalhub has a one year low of C$2.35 and a one year high of C$7.67.

Vitalhub (TSE:VHIGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.07 by C($0.03). Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. The firm had revenue of C$15.26 million during the quarter, compared to the consensus estimate of C$14.12 million. Sell-side analysts expect that Vitalhub will post 0.2700115 earnings per share for the current fiscal year.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Featured Stories

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with's FREE daily email newsletter.